{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:50Z","timestamp":1791355910356,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T00:00:00Z","timestamp":1353628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s40264-012-0002-x","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T18:09:48Z","timestamp":1355940588000},"page":"13-23","source":"Crossref","is-referenced-by-count":77,"title":["A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases"],"prefix":"10.1007","volume":"36","author":[{"given":"Preciosa M.","family":"Coloma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Avillach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"Schuemie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ferrajolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fourrier-R\u00e9glat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Patadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van der Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,23]]},"reference":[{"issue":"2","key":"2_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1099-1557(199903\/04)8:2<147::AID-PDS413>3.0.CO;2-6","volume":"8","author":"WK Amery","year":"1999","unstructured":"Amery WK. Signal generation from spontaneous adverse event reports. Pharmacoepidemiol Drug Saf. 1999;8(2):147\u201350.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2_CR2","doi-asserted-by":"crossref","unstructured":"Coloma PM, Trifir\u00f2 G, Schuemie MJ et al. On behalf of the EU-ADR Consortium. Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol Drug Saf. Epub 2012 Feb 8.","DOI":"10.1002\/pds.3197"},{"issue":"5","key":"2_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2125.2004.02203.x","volume":"58","author":"M Hauben","year":"2004","unstructured":"Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol. 2004;58(5):560\u20132.","journal-title":"Br J Clin Pharmacol"},{"key":"2_CR4","unstructured":"World Health Organization. Safety of medicines: a guide to detecting and reporting adverse drug reactions [online]. Available from URL: http:\/\/whqlibdoc.who.int\/hq\/2002\/WHO_EDM_QSM_2002.2.pdf . Accessed 10 Sep 2011."},{"issue":"2","key":"2_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-200932020-00003","volume":"32","author":"M Hauben","year":"2009","unstructured":"Hauben M, Aronson JK. Defining \u2018signal\u2019 and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf. 2009;32(2):99\u2013110.","journal-title":"Drug Saf"},{"key":"2_CR6","first-page":"43","volume":"148","author":"G Trifir\u00f2","year":"2009","unstructured":"Trifir\u00f2 G, Fourrier-Reglat A, Sturkenboom MC, et al. The EU-ADR project: preliminary results and perspective. Stud Health Technol Inform. 2009;148:43\u20139.","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"2_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.2053","volume":"20","author":"PM Coloma","year":"2011","unstructured":"Coloma PM, Schuemie MJ, Trifir\u00f3 G, on behalf of the EU-ADR Consortium, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20(1):1\u201311.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"2_CR8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pds.1836","volume":"18","author":"G Trifir\u00f2","year":"2009","unstructured":"Trifir\u00f2 G, Pariente A, Coloma PM. On behalf of the EU-ADR consortium, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf. 2009;18(12):1176\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2_CR9","unstructured":"Avillach P, Dufour JC, Diallo G, et al. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution to the European EU-ADR project. AMIA 2010 Annual Symposium (2010)."},{"issue":"database issue","key":"2_CR10","doi-asserted-by":"crossref","first-page":"D267","DOI":"10.1093\/nar\/gkh061","volume":"32","author":"O Bodenreider","year":"2004","unstructured":"Bodenreider O. The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32(database issue):D267\u201370.","journal-title":"Nucleic Acids Res"},{"key":"2_CR11","unstructured":"European Medicines Agency. European public assessment reports [online]. Available from URL: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=\/pages\/medicines\/landing\/epar_search.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d125 . Accessed 20 Sep 2011."},{"key":"2_CR12","unstructured":"DailyMed [online]. Available from URL: http:\/\/dailymed.nlm.nih.gov\/dailymed\/about.cfm . Accessed 20 Sep 2011."},{"key":"2_CR13","unstructured":"Electronic Medicines Compendium (for drugs licensed in the United Kingdom). http:\/\/www.medicines.org.uk\/emc\/ . Accessed 20 Sep 2011."},{"key":"2_CR14","unstructured":"Micromedex. https:\/\/www.thomsonhc.com\/hcs\/librarian\/ . Accessed 20 Sep 2011."},{"key":"2_CR15","unstructured":"RxList [online]. Available from URL: http:\/\/www.rxlist.com\/ . Accessed 20 Sep 2011."},{"key":"2_CR16","unstructured":"Drugbank: open data drug and drug target database [online]. Available from URL: http:\/\/www.drugbank.ca\/ . Accessed 20 Sep 2011."},{"key":"2_CR17","first-page":"25","volume":"166","author":"G Trifir\u00f2","year":"2011","unstructured":"Trifir\u00f2 G, Patadia V, Schuemie MJ, et al. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform. 2011;166:25\u201330.","journal-title":"Stud Health Technol Inform"},{"issue":"7","key":"2_CR18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0149-2918(04)90181-6","volume":"26","author":"W DuMouchel","year":"2004","unstructured":"DuMouchel W, Smith ET, Beasley R, et al. Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther. 2004;26(7):1092\u2013104.","journal-title":"Clin Ther"},{"issue":"9237","key":"2_CR19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"issue":"9","key":"2_CR20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/106002809603000906","volume":"30","author":"DT Kennedy","year":"1996","unstructured":"Kennedy DT, Hayney MS, Lake KD. Azathioprine and allopurinol: the price of an avoidable drug interaction. Ann Pharmacother. 1996;30(9):951\u20134.","journal-title":"Ann Pharmacother"},{"issue":"7040","key":"2_CR21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bmj.312.7040.1215","volume":"312","author":"N Black","year":"1996","unstructured":"Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312(7040):1215\u20138.","journal-title":"BMJ"},{"issue":"5","key":"2_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1503\/cmaj.050873","volume":"174","author":"PN Papanikolaou","year":"2006","unstructured":"Papanikolaou PN, Christidi GD, Ioannidis JP. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006;174(5):635\u201341.","journal-title":"CMAJ"},{"issue":"7456","key":"2_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/bmj.329.7456.44","volume":"329","author":"BH Stricker","year":"2004","unstructured":"Stricker BH, Psaty BM. Detection, verification, and quantification of adverse drug reactions. BMJ. 2004;329(7456):44\u20137.","journal-title":"BMJ"},{"issue":"17","key":"2_CR24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMp038145","volume":"349","author":"W Ray","year":"2003","unstructured":"Ray W. Population-based studies of adverse drug effects. N Engl J Med. 2003;349(17):1592\u20134.","journal-title":"N Engl J Med"},{"issue":"6","key":"2_CR25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00002018-200023060-00004","volume":"23","author":"M Lindquist","year":"2000","unstructured":"Lindquist M, St\u00e5hl M, Bate A, et al. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database. Drug Saf. 2000;23(6):533\u201342.","journal-title":"Drug Saf"},{"issue":"10","key":"2_CR26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2165\/00002018-200427100-00004","volume":"27","author":"M Hauben","year":"2004","unstructured":"Hauben M, Reich L. Safety related drug-labelling changes: findings from two data mining algorithms [published erratum appears in Drug Saf 2006; 29 (12): 1191]. Drug Saf. 2004;27(10):735\u201344.","journal-title":"Drug Saf"},{"issue":"6","key":"2_CR27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00002018-200932060-00007","volume":"32","author":"AM Hochberg","year":"2009","unstructured":"Hochberg AM, Hauben M, Pearson RK, et al. An evaluation of three signal-detection algorithms using a highly inclusive reference event database. Drug Saf. 2009;32(6):509\u201325.","journal-title":"Drug Saf"},{"issue":"4","key":"2_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pds.849","volume":"12","author":"P Waller","year":"2003","unstructured":"Waller P. Dealing with uncertainty in drug safety: lessons for the future from sertindole. Pharmacoepidemiol Drug Saf. 2003;12(4):283\u20137. (discussion 289\u201390).","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2_CR29","first-page":"239","volume-title":"Pharmacoepidemiology and therapeutic risk management","author":"A Bate","year":"2008","unstructured":"Bate A, Edwards IR. Data mining techniques in pharmacovigilance. In: Hartzema AG, Tilson HH, Chan KA, editors. Pharmacoepidemiology and therapeutic risk management. Cincinnati: Harvey Whitney; 2008. p. 239\u201372."},{"issue":"9689","key":"2_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(09)60252-X","volume":"374","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Schapira AH, Mikhailidis DP, et al. Drug-induced fibrotic valvular heart disease. Lancet. 2009;374(9689):577\u201385.","journal-title":"Lancet"},{"issue":"1","key":"2_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2125.2005.02510.x","volume":"61","author":"JG Levine","year":"2006","unstructured":"Levine JG, Tonning JM, Szarfman A. Reply: the evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned. Br J Clin Pharmacol. 2006;61(1):105\u201313 (author reply 115\u20137).","journal-title":"Br J Clin Pharmacol"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-012-0002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-012-0002-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-012-0002-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:27Z","timestamp":1559490087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-012-0002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,23]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s40264-012-0002-x","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,23]]}}}